Autologous hemopoietic stem cell transplantation in the treatment of multiple sclerosis: rationale and clinical experience
- 15 August 2004
- journal article
- review article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 223 (1) , 53-58
- https://doi.org/10.1016/j.jns.2004.04.020
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation–based conditioning regimen to prevent disease progression in patients with high disability scoresBlood, 2003
- High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosisBlood, 2003
- Collection of hematopoietic stem cells from patients with autoimmune diseasesBone Marrow Transplantation, 2001
- Autologous haematopoietic stem cell transplants for autoimmune disease – feasibility and transplant-related mortalityBone Marrow Transplantation, 1999
- Acute/relapsing experimental autoimmune encephalomyelitis: Induction of long lasting, antigen-specific tolerance by syngeneic bone marrow transplantationMultiple Sclerosis Journal, 1999
- Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot studyBone Marrow Transplantation, 1997
- Allogeneic bone marrow transplant for chronic myelogenous leukemia in a patient with multiple sclerosisBone Marrow Transplantation, 1997
- Immune ablation followed by allogeneic or autologous bone marrow transplantation: A new treatment for severe autoimmune diseases?The International Journal of Cell Cloning, 1994
- Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation.Journal of Clinical Investigation, 1993
- Circulating IgG Antibodies against Factors IX and VIII in Multiple SclerosisActa Haematologica, 1976